학술논문
'학술논문'
에서 검색결과 134,823건 | 목록
1~10
Academic Journal
Huang, Feng; Humayun, Muhammad; Li, Gang; Fan, Ting-Ting; Wang, Wen-Lin; Cao, Yu-Lin; Nikiforov, Anton; Wang, Chun-Dong; Wang, Jing
Rare Metals. 43(7):3161-3172
Academic Journal
Azim HA Jr; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Niman SM; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Partridge AH; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Demeestere I; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Ruggeri M; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Gelber RD; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Pagani O; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.; Peccatori FA; Hatem A. Azim Jr, MD, PhD, Cairo Cure Oncology Center, Cairo, Egypt; Samuel M. Niman, MSc, International Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; Ann H. Partridge, MD, Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, Harvard Medical School, Boston, MA; Isabelle Demeestere, MD, PhD, Research Laboratory on Human Reproduction, Université Libre de Bruxelles (ULB), Brussels, Belgium, Gynecology and Obstetrics Department, Fertility Clinic, HUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium; Monica Ruggeri, MM, Program for Young Patients, International Breast Cancer Study Group, A Division of ETOP IBCSG Partners Foundation, Bern, Switzerland; Richard D. GelberInternational Breast Cancer Study Group Statistical Center, Boston, MA, Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, Frontier Science Foundation, Boston, MA, Harvard TH Chan School of Public Health, Boston, MA; Olivia Pagani, MD, Geneva University Hospitals, Geneva, Switzerland, Lugano University, Lugano, Switzerland, Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland; and Fedro A. Peccatori, MD, PhD, Fertility and Procreation Unit, Gynecologic Oncology Program, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Xiao, Gang; Zhang, Xiao-Lei; Wang, Si-Qi; Lai, Shi-Xin; Nie, Ting-Ting; Chen, Yao-Wen; Zhuang, Cai-Yu; Yan, Gen; Wu, Ren-Hua
Scientific Reports. 14(1)
Conference
2023 IEEE International Magnetic Conference - Short Papers (INTERMAG Short Papers) Magnetic Conference - Short Papers (INTERMAG Short Papers), 2023 IEEE International. :1-2 May, 2023
검색 결과 제한하기
제한된 항목
[검색어] Z. Wen
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어